December 21, 2013Open Access
View Full PaperKidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury
Key Points
Key points are not available for this paper at this time.
Abstract
Urinary biomarkers of kidney injury are elevated in patients with cirrhosis and AKI due to ATN. Incorporating biomarkers into clinical decision making has the potential to more accurately guide treatment by establishing which patients have structural injury underlying their AKI. Further research is required to document biomarkers specific to HRS.